E213 - The PsychopharmaStahlogy Show: Is The ...

In this episode, Dr. Andy Cutler speaks with Dr. Thomas Schwartz about insomnia related to antidepressant discontinuation, including how rebound and withdrawal symptoms can emerge when tapering or stopping treatment. They review the underlying mechanisms, clinical risk factors, a ...  Show more

In this episode, Dr. Andy Cutler speaks with Dr. Holly Swartz about the critical role of sleep and circadian rhythms in bipolar disorder, including how sleep disturbance can function as both a symptom and trigger of mood episodes. They discuss how clinicians can better assess sle ...  Show more

In this episode, Joe interviews Josh Lipson, a Ph.D. candidate in clinical psychology at Columbia University, whose research explores the relationship between psychedelics, mystical experiences, and mental health. He discusses the complexities of studying psychedelics in real-wor ...  Show more

In this episode, Ben Malcolm (the Spirit Pharmacist) brings us into the intersection of psychedelics and pharmacology. We discuss practical considerations, such as guidelines for safely tapering off SSRIs before embarking on a psychedelic experience and navigating contraindica ...

We have been hearing a lot about the use of psychedelics to treat mental health in recent years, but what does that actually entail? What do psychedelics actually do to our brain? What would it feel like? What would it look like if psychedelics were as easily prescribed as antide ...  Show more

Dr. K breaks down how psychedelics actually work not from hype or hearsay, but through neuroscience, psychiatry, and lived experience. He explains that psychedelics don’t “heal” you by themselves; they temporarily put the brain into edit mode, a state of heightened neuroplasticit ...  Show more